-Bloomberg
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
The European Commission has approved AstraZeneca plc (NASDAQ:AZN) and Sanofi SA’s (NASDAQ:SNY) Beyfortus (nirsevimab) long-acting antibody to prevent respiratory syncytial virus (RSV) lower…